Search research articles
Contact Us
Filters
Showing results (221-230 of 248) with videos related to
Page
of 25
Sort By:
Journal of Virology
|
May 1, 1997
Purification of the simian virus 40 (SV40) T antigen DNA-binding domain and characterization of its interactions with the SV40 origin
W S Joo, X Luo, D Denis, et al.
Molecular Pharmacology
|
May 17, 2001
Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor
M D Ungrin, M C Carrière, D Denis, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 1, 1994
Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin
J Y Reginster, D Denis, R Deroisy, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 2, 2018
Acanthopanax senticosus reduces brain injury in mice exposed to low linear energy transfer radiation
A Yingyu Zhou, B Wei Song, C Yilei Fu, et al.
Scandinavian Journal of Rheumatology
|
January 1, 1990
Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone
J Y Reginster, C Gennari, C Mautalen, et al.
Journal of Medicinal Chemistry
|
September 17, 1993
Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816
J H Hutchinson, D Riendeau, C Brideau, et al.
Bioorganic & Medicinal Chemistry
|
August 16, 2001
Structure-activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor
H Juteau, Y Gareau, M Labelle, et al.
Bone
|
January 1, 1988
Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone
J Y Reginster, A M Jeugmans-Huynen, A Albert, et al.
Canadian Journal of Physiology and Pharmacology
|
May 1, 1989
L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor
J Gillard, A W Ford-Hutchinson, C Chan, et al.
Canadian Journal of Physiology and Pharmacology
|
December 1, 1986
L-648,051, sodium 4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)- propylsulfonyl]-gamma-oxo-benzenebutanoate: a leukotriene D4 receptor antagonist
T R Jones, Y Guindon, R Young, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 248) with videos related to
Sort By:
Page
of 25
Journal of Virology
|
May 1, 1997
Purification of the simian virus 40 (SV40) T antigen DNA-binding domain and characterization of its interactions with the SV40 origin
W S Joo, X Luo, D Denis, et al.
Molecular Pharmacology
|
May 17, 2001
Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor
M D Ungrin, M C Carrière, D Denis, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 1, 1994
Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin
J Y Reginster, D Denis, R Deroisy, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 2, 2018
Acanthopanax senticosus reduces brain injury in mice exposed to low linear energy transfer radiation
A Yingyu Zhou, B Wei Song, C Yilei Fu, et al.
Scandinavian Journal of Rheumatology
|
January 1, 1990
Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone
J Y Reginster, C Gennari, C Mautalen, et al.
Journal of Medicinal Chemistry
|
September 17, 1993
Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816
J H Hutchinson, D Riendeau, C Brideau, et al.
Bioorganic & Medicinal Chemistry
|
August 16, 2001
Structure-activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor
H Juteau, Y Gareau, M Labelle, et al.
Bone
|
January 1, 1988
Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of bone
J Y Reginster, A M Jeugmans-Huynen, A Albert, et al.
Canadian Journal of Physiology and Pharmacology
|
May 1, 1989
L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor
J Gillard, A W Ford-Hutchinson, C Chan, et al.
Canadian Journal of Physiology and Pharmacology
|
December 1, 1986
L-648,051, sodium 4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)- propylsulfonyl]-gamma-oxo-benzenebutanoate: a leukotriene D4 receptor antagonist
T R Jones, Y Guindon, R Young, et al.
Page
of 25